Maravai LifeSciences Holdings, Inc.
HealthcareNASDAQ:MRVI · NASDAQ Global Select
-$0.23 today
Vol 1.66M · Avg 2.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+133.80%
Period High
$5.21
Period Low
$2.01
Latest
$4.98
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Septerna, Inc.
NASDAQ:SEPN
$1.62B
Tyra Biosciences, Inc.
NASDAQ:TYRA
$1.61B
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$1.46B
Vir Biotechnology, Inc.
NASDAQ:VIR
$1.45B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.19B
Kura Oncology, Inc.
NASDAQ:KURA
$803.41M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$515.41M
Prime Medicine, Inc.
NASDAQ:PRME
$501.21M
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$212.27M
What is the latest MRVI filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does MRVI have?
Intrinsic Alpha currently shows 20 recent filings for MRVI.
Explore More
Continue the stock analysis
Jump to another research area for this company.